相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey
Guirong Wang et al.
JOURNAL OF INFECTION (2021)
Determinants of tuberculosis treatment interruption among patients in Vihiga County, Kenya
Paul Waliaula Wekunda et al.
PLOS ONE (2021)
Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults
Lauren S. Peetluk et al.
BMJ OPEN (2021)
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil
M. Bhering et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)
Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013
Hui Xia et al.
MICROBIOLOGY SPECTRUM (2021)
Characteristics of rifampicin-resistant tuberculosis detection in China, 2015-2019
Wei Su et al.
INFECTIOUS DISEASES OF POVERTY (2021)
Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study
Le Hong Van et al.
BMC INFECTIOUS DISEASES (2020)
Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis
Kefyalew Addis Alene et al.
PLOS ONE (2020)
Treatment outcomes of multidrug-resistant tuberculosis in Hangzhou, China, 2011 to 2015
Qingchun Li et al.
MEDICINE (2020)
Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014): A retrospective record-based study
Nandini Sharma et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study
Mariam El Hamdouni et al.
BMC INFECTIOUS DISEASES (2019)
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015
Ivan S. Pradipta et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis
Luiz Henrique Arroyo et al.
REVISTA DE SAUDE PUBLICA (2019)
Cost of three models of care for drug-resistant tuberculosis patients in Nigeria
Florence O. Bada et al.
BMC INFECTIOUS DISEASES (2019)
Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009-2013
L. Zhang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
Kefyalew Addis Alene et al.
JOURNAL OF INFECTION (2018)
Treatment outcome of multidrug-resistant tuberculosis in Japan - the first cross-sectional study of Japan tuberculosis surveillance data
Lisa Kawatsu et al.
BMC INFECTIOUS DISEASES (2018)
Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico
B. E. Abdelbary et al.
EPIDEMIOLOGY AND INFECTION (2017)
Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model
X. -M. Wang et al.
EPIDEMIOLOGY AND INFECTION (2017)
Sociodemographic and Clinical Risk Factors Associated With Tuberculosis Mortality in the United States, 2009-2013
Haylea A. Hannah et al.
PUBLIC HEALTH REPORTS (2017)
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review
Francesco Di Gennaro et al.
TUBERCULOSIS (2017)
Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies
Kelemu Tilahun Kibret et al.
INFECTIOUS DISEASES OF POVERTY (2017)
Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis
Mayara Lisboa Bastos et al.
BMC INFECTIOUS DISEASES (2017)
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
Kefyalew Addis Alene et al.
BMC INFECTIOUS DISEASES (2017)
Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014
Thelma E. Tupasi et al.
EMERGING INFECTIOUS DISEASES (2016)
Cost-effectiveness of a comprehensive programme for drug-resistant tuberculosis in China
Christopher Fitzpatrick et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2015)
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis
A. Toczek et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
National Survey of Drug-Resistant Tuberculosis in China
Yanlin Zhao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
分享论文
